IP Library Granted Patent US 9,572,912
Granted Patent B2
US 9,572,912 · App. 14/256,911 · Granted Feb 21, 2017

Demineralized bone fibers having controlled geometry and shapes and methods thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,572,912
App. No.
14/256,911
Granted
Feb 21, 2017
Kind
B2
Abstract

A bone repair composition and methods thereof include elongated bone fibers made from cortical bone in which a plurality of approximately uniform bone fibers is made into various implant shapes conducive for various applications. The bone fiber compositions may be in the form of a cavity, ball, pellet, wrap, strip, cylinder, cone, putty, gel, or injectable slurry.

Claims (18)

1. A bone repair composition, comprising:

a plurality of elongated bone fibers cut from cortical bone demineralized to a calcium content of no more than 10%;

the plurality of elongated bone fibers cut along the direction of collagen fibers in the demineralized bone;

the plurality of elongated bone fibers having a length from about 1 cm to about 30 cm, a width from about 0.05 mm to about 4 mm, and a thickness from about 0.05 mm to about 4 mm; and

the plurality of elongated bone fibers having a plurality of cross sections with at least 60% uniformity within one standard deviation.

2. The bone repair composition of claim 1 , wherein the plurality of elongated bone fibers are in a form selected from the group consisting of a cavity, ball, pellet, sheet, strip, cylinder, cone, putty, and gel.

3. The bone repair composition of claim 2 , wherein the cavity is selected from a boat, cup, or box shape.

4. The bone repair composition of claim 1 , wherein the plurality of demineralized elongated bone fibers is in a form of a sheet.

5. The bone repair composition of claim 4 , wherein the sheet has a thickness from about 0.5 to about 10 mm, a length from about 2 inches to about 8 inches, and a width from about 2 inches to about 8 inches.

6. The bone repair composition of claim 4 , wherein the sheet comprises a first region of demineralized elongated bone fibers and a second region of demineralized elongated bone fibers, in which the demineralized elongated bone fibers of the first region are more dense than the demineralized elongated bone fibers of the second region.

7. The bone repair composition of claim 6 , wherein the first region of demineralized elongated bone fibers and the second region of demineralized elongated bone fibers form a grid pattern.

8. The bone repair composition of claim 4 , wherein the sheet comprises holes.

9. The bone repair composition of claim 1 , further comprising an additive selected from the group consisting of autologous bone chips, bone marrow aspirate, a morcellized autograft, bone marrow cells, mesenchymal stem cells, oxygenating materials, oxygen generating compounds, growth factors, antibiotics, anti-neoplastic agents, and combinations thereof.

10. The bone repair composition of claim 1 , wherein the plurality of demineralized elongated bone fibers is in a form of a putty.

11. The bone repair composition of claim 10 , wherein the putty further comprises an excipient.

12. The bone repair composition of claim 11 , wherein the excipient is selected from the group of glycerol, lecithin, sodium carboxy methyl cellulose, polyoxamer, hyaluronic acid, and derivatized hyaluronic acid.

13. The bone repair composition of claim 1 , wherein the at least 60% uniformity is at least 90% uniformity.

14. The bone repair composition of claim 1 , wherein the plurality of elongated bone fibers have a width from about 0.2 mm to about 1 mm.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2025
From: THERACELL, LLC
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.
Reel/Frame 072388/0197 →
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
CHANGE OF NAME Recorded Oct 11, 2023
From: THERACELL, INC.
To: THERACELL, LLC
Reel/Frame 065219/0102 →
SECURITY INTEREST Recorded Apr 4, 2022
From: THERACELL, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 059486/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2021
From: SCARBOROUGH, NELSON L.; PATT, BRADLEY; CARTER, ANDREW J.
To: THERACELL, INC.
Reel/Frame 057469/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2014
From: CARTER, ANDREW J.; SCARBOROUGH, NELSON L.; PATT, BRADLEY
To: THERACELL, INC.
Reel/Frame 032794/0816 →